We are looking for an exceptional Board-Certified physician to join our team as a Medical Strategy Lead to help us expand our CAGT portfolio, with an emphasis on Gene Therapy/Gene Editing platforms ...
We are looking for an exceptional Board-Certified physician to join our team as a Medical Strategy Lead to help us expand our CAGT portfolio, with an emphasis on Gene Therapy/Gene Editing platforms ...
The successful candidate will have the expertise to develop new courses and teach graduate-level courses in Cell and Gene Therapy, including cell and gene therapy lab, gene editing, gene augmentation ...
The successful candidate will have the expertise to develop new courses and teach graduate-level courses in Cell and Gene Therapy, including cell and gene therapy lab, gene editing, gene augmentation ...
The successful candidate will have the expertise to develop new courses and teach graduate-level courses in Cell and Gene Therapy, including cell and gene therapy lab, gene editing, gene augmentation ...
The successful candidate will have the expertise to develop new courses and teach graduate-level courses in Cell and Gene Therapy, including cell and gene therapy lab, gene editing, gene augmentation ...
Its goal is to develop and advance to the clinic gene-editing-based therapies for two severe inborn errors of the immune system. The SRA3 represents a linchpin position within the nonclinical (IND ...
Its goal is to develop and advance to the clinic gene-editing-based therapies for two severe inborn errors of the immune system. The SRA3 represents a linchpin position within the nonclinical (IND ...
VCN, gene editing proficiency, infectious titer, genomic titer, rapid mycoplasma, surrogate RCL, residual DNA, etc. * Subject matter expert supporting routine testing of final product (GMP ...
VCN, gene editing proficiency, infectious titer, genomic titer, rapid mycoplasma, surrogate RCL, residual DNA, etc. * Subject matter expert supporting routine testing of final product (GMP ...
VCN, gene editing proficiency, infectious titer, genomic titer, rapid mycoplasma, surrogate RCL, residual DNA, etc. * Subject matter expert supporting routine testing of final product (GMP ...
VCN, gene editing proficiency, infectious titer, genomic titer, rapid mycoplasma, surrogate RCL, residual DNA, etc. * Subject matter expert supporting routine testing of final product (GMP ...
Scientist - Off-Target Genomics (Gene Therapy)
Boston, MA · On-site
$104K - $112K/yr
... gene editing therapeutics ... This role focuses on evaluating off-target effects, genomic integrity, and emerging genome editing ...
Scientist - Off-Target Genomics (Gene Therapy)
Boston, MA · On-site
$104K - $112K/yr
... gene editing therapeutics ... This role focuses on evaluating off-target effects, genomic integrity, and emerging genome editing ...
Scientist - Off-Target Genomics (Gene Therapy)
$104K - $112K/yr
... gene editing therapeutics ... This role focuses on evaluating off-target effects, genomic integrity, and emerging genome editing ...
Scientist - Off-Target Genomics (Gene Therapy)
$104K - $112K/yr
... gene editing therapeutics ... This role focuses on evaluating off-target effects, genomic integrity, and emerging genome editing ...
Research Associate II - Senior Research Associate I, Therapeutic Translation
Emeryville, CA · On-site
Your work will be foundational for expanding our gene editing toolbox and translating these advances to new therapeutic opportunities. The ideal candidate will have experience with molecular biology ...
Research Associate II - Senior Research Associate I, Therapeutic Translation
Emeryville, CA · On-site
Your work will be foundational for expanding our gene editing toolbox and translating these advances to new therapeutic opportunities. The ideal candidate will have experience with molecular biology ...
VCN, gene editing proficiency, infectious titer, genomic titer, rapid mycoplasma, surrogate RCL, residual DNA, etc.Subject matter expert supporting routine testing of final product (GMP), stability ...
VCN, gene editing proficiency, infectious titer, genomic titer, rapid mycoplasma, surrogate RCL, residual DNA, etc.Subject matter expert supporting routine testing of final product (GMP), stability ...
Research Associate II - Senior Research Associate I, Therapeutic Translation
Emeryville, CA · On-site
$83K - $110K/yr
Your work will be foundational for expanding our gene editing toolbox and translating these advances to new therapeutic opportunities. The ideal candidate will have experience with molecular biology ...
Research Associate II - Senior Research Associate I, Therapeutic Translation
Emeryville, CA · On-site
$83K - $110K/yr
Your work will be foundational for expanding our gene editing toolbox and translating these advances to new therapeutic opportunities. The ideal candidate will have experience with molecular biology ...
Associate Director, Protein Engineering
Cambridge, MA · On-site
$178K - $192K/yr
Arbor Biotechnologies™, a next-generation gene editing company based in Cambridge, MA, is advancing a pipeline of novel gene editing therapeutics to address a wide range of genetic conditions ...
Associate Director, Protein Engineering
Cambridge, MA · On-site
$178K - $192K/yr
Arbor Biotechnologies™, a next-generation gene editing company based in Cambridge, MA, is advancing a pipeline of novel gene editing therapeutics to address a wide range of genetic conditions ...
Research Investigator, Senior
Philadelphia, PA · On-site
$79K - $105K/yr
Our lab specializes in therapeutic gene editing, with a specific focus on using next-generation CRISPR tools for in vivo gene editing to address cardiovascular, metabolic, and other diseases. We are ...
Research Investigator, Senior
Philadelphia, PA · On-site
$79K - $105K/yr
Our lab specializes in therapeutic gene editing, with a specific focus on using next-generation CRISPR tools for in vivo gene editing to address cardiovascular, metabolic, and other diseases. We are ...
Submit your resume for future full time openings
Cambridge, MA · On-site
$141K - $182K/yr
Beam's suite of gene editing technologies is anchored by base editing, a proprietary technology that is designed to enable precise, predictable and efficient single base changes, at targeted genomic ...
Submit your resume for future full time openings
Cambridge, MA · On-site
$141K - $182K/yr
Beam's suite of gene editing technologies is anchored by base editing, a proprietary technology that is designed to enable precise, predictable and efficient single base changes, at targeted genomic ...
Preventive Misfits - Passionate about Preventive but don't see a role?
South San Francisco, CA · On-site
Our mission is to determine whether the newest generation of gene editing technologies can be used safely and responsibly to correct devastating genetic conditions for future children. If proven to ...
Preventive Misfits - Passionate about Preventive but don't see a role?
South San Francisco, CA · On-site
Our mission is to determine whether the newest generation of gene editing technologies can be used safely and responsibly to correct devastating genetic conditions for future children. If proven to ...
Submit your resume for future Manufacturing and Quality roles located in RTP, NC
Durham, NC · On-site
$72K - $92K/yr
Beam's suite of gene editing technologies is anchored by base editing, a proprietary technology that is designed to enable precise, predictable and efficient single base changes, at targeted genomic ...
Submit your resume for future Manufacturing and Quality roles located in RTP, NC
Durham, NC · On-site
$72K - $92K/yr
Beam's suite of gene editing technologies is anchored by base editing, a proprietary technology that is designed to enable precise, predictable and efficient single base changes, at targeted genomic ...
Verve Therapeutics, a wholly owned subsidiary of Eli Lilly and Company, is pioneering the development of in vivo gene editing therapies to transform the treatment of cardiovascular disease. The ...
Verve Therapeutics, a wholly owned subsidiary of Eli Lilly and Company, is pioneering the development of in vivo gene editing therapies to transform the treatment of cardiovascular disease. The ...
Verve Therapeutics, a wholly owned subsidiary of Eli Lilly and Company, is pioneering the development of in vivo gene editing therapies to transform the treatment of cardiovascular disease. The ...
Verve Therapeutics, a wholly owned subsidiary of Eli Lilly and Company, is pioneering the development of in vivo gene editing therapies to transform the treatment of cardiovascular disease. The ...
Manager/Senior Manager Regulatory Affairs - Advertising, Labeling, and Promotion
Cambridge, MA · On-site
$130K - $190K/yr
Beam's suite of gene editing technologies is anchored by base editing, a proprietary technology that is designed to enable precise, predictable and efficient single base changes, at targeted genomic ...
Manager/Senior Manager Regulatory Affairs - Advertising, Labeling, and Promotion
Cambridge, MA · On-site
$130K - $190K/yr
Beam's suite of gene editing technologies is anchored by base editing, a proprietary technology that is designed to enable precise, predictable and efficient single base changes, at targeted genomic ...
Design, execute, and optimize robust molecular and/or cell-based assays to measure on- and off-target activity of novel gene editing systems using a combination of targeted and genome-wide analytical ...
Design, execute, and optimize robust molecular and/or cell-based assays to measure on- and off-target activity of novel gene editing systems using a combination of targeted and genome-wide analytical ...
Gene Editing information
See salary details
$35K - $42.1K
14% of jobs
$42.1K - $49.2K
4% of jobs
$53.6K is the 25th percentile. Wages below this are outliers.
$49.2K - $56.3K
11% of jobs
$56.3K - $63.4K
19% of jobs
The median wage is $64.4K / yr.
$63.4K - $70.5K
11% of jobs
$70.5K - $77.5K
5% of jobs
$82.5K is the 75th percentile. Wages above this are outliers.
$77.5K - $84.6K
15% of jobs
$84.6K - $91.7K
8% of jobs
$91.7K - $98.8K
2% of jobs
$98.8K - $105.9K
5% of jobs
$105.9K - $113K
5% of jobs
$35K
$71.8K
$113K
How much do gene editing jobs pay per year?
What are some typical daily tasks and responsibilities in a Gene Editing role?
Professionals in Gene Editing roles often spend their days designing and executing experiments, analyzing genetic sequences, and developing new methods for modifying DNA in various organisms. You may also be responsible for maintaining detailed lab documentation, troubleshooting experimental challenges, and collaborating with interdisciplinary teams of biologists, chemists, and data analysts. Common tasks include preparing genetic constructs, operating advanced laboratory equipment, and interpreting research results to inform ongoing projects. These responsibilities are integral to driving scientific discovery and bringing new gene-editing applications to practical use.
What are the key skills and qualifications needed to thrive in the Gene Editing position, and why are they important?
To thrive in Gene Editing, you need a strong background in molecular biology, genetics, and biotechnology, typically supported by an advanced degree such as a PhD or MS in related fields. Familiarity with gene editing tools like CRISPR-Cas9, PCR, DNA sequencing platforms, and relevant software is essential, along with potential certifications in laboratory safety or bioinformatics. Attention to detail, strong problem-solving abilities, and collaborative communication skills are valuable for navigating complex experiments and coordinating with research teams. These competencies are vital to ensure experimental accuracy, maintain compliance with regulations, and drive innovation in this rapidly evolving scientific area.
What is a Gene Editing job?
A Gene Editing job involves researching, developing, and applying techniques to modify DNA in organisms to achieve desired traits or correct genetic defects. Professionals in this field work with technologies like CRISPR, TALENs, and zinc finger nucleases to edit genes for medical, agricultural, or scientific purposes. Roles may include laboratory research, therapeutic development, or regulatory compliance. Scientists in this field typically have backgrounds in genetics, molecular biology, or biotechnology.
Full-time
Posted 12 days ago
IQVIA rating
8.1
Based on 51 frontline employees who took The Breakroom Quiz
53rd of 203 rated it services
Job description
The IQVIA Cell and Gene Therapy Center of Excellence (CAGT COE), a hub of CAGT clinical innovation, is growing! We are looking for an exceptional Board-Certified physician to join our team as a Medical Strategy Lead to help us expand our CAGT portfolio, with an emphasis on Gene Therapy/Gene Editing platforms, and advance this dynamic and rapidly expanding area of clinical development.The CAGT Medical Strategy Lead is a subject matter expert with experience in clinical research and clinical trials in CAGT and especially in the areas of Gene Therapy/Gene Editing, who will be a champion for CAGT across IQVIA.The key remit of the role is drive growth of the IQVIA CAGT portfolio through scientific and clinical expertise. The CAGT Medical Strategy Lead will be charged with using his/her clinical, scientific, and operational knowledge to harness the vast IQVIA data and clinical trial resources to develop innovative, data-driven, and patient-centered solutions for CAGT trials.The CAGT Medical Strategy Lead will provide clinical and scientific expertise to all IQVIA divisions as requested and will collaborate closely with indication-specific teams to develop integrated strategies for CAGT clinical trials and studies.The CAGT Medical Strategy Lead will also be responsible for early engagement business development activities, providing scientific knowledge and expertise to guide sponsors in CAGT development. As a subject matter expert in CAGT, the CAGT Medical Strategy Lead will drive thought leadership activities including presentations, publications, and interactions with the medical scientific community.
Responsibilities
- Accountable and responsible for creating innovative, evidence-based, and patient-centered delivery strategies and solutions for CAGT trials or studies, addressing the specific needs and challenges of each customer.
- In partnership with indication-specific Medical Strategy, Operations, Sales, and other functions, responsible for award of strategic and tactical new business to achieve annual Gross New Business targets.
- Responsible for the inclusion of CAGT elements into proposals.
- Provide scientific, clinical, and operational advice to internal stakeholders developing proposals: this may include, but is not limited to, providing the strategy to protocol design/clinical development plan, mining data to address important clinical questions relevant to the study, reviewing the protocol for scientific/regulatory soundness and feasibility, logistics challenges, identification of target site and principal investigator profiles, anticipated patient recruitment, standard of care and competitive landscape.
- Support preparation of customer and bid defense meetings, e.g. training and preparation of the assigned project team; provide specific content; ensure presentation focus and content effectively conveys CAGT strategy.
- Attends and presents at customer meeting, or bid defense or partnership meetings, as required.
- Participates in strategic business development activities including presentations to prospective clients and professional meetings.
- Maintains awareness of industry pipeline and scientific and business landscape; supports due diligence research of the CAGT landscape.
- Leads CAGT thought leadership at IQVIA which may include publications, presentations, and taking a leadership role in scientific activities.
Qualifications
- A physician (MD or DO) or physician/scientist (MD/PhD) with experience in CAGT and especially in gene therapy/gene editing.
- A degree from an accredited and internationally recognized school is required.
- Certification in any medical sub-specialty will be considered and preference will be given to candidates with formal training in Neurology, Medical Genetics, or Cardiology.
- Highly qualified and experienced candidates with other terminal degrees such as a PhD or Pharm D will also be considered.
- At least 5 years clinical research relevant experience, including hands on operational delivery and/or drug development experience in gene therapy/gene editing.
- Robust and current knowledge of scientific, clinical, regulatory, commercial and competitive landscape in CAGT, especially in gene therapy/gene editing.
- Excellent skills in providing consultation and advice on multiple assignments are required, as well as initiative and flexibility.
- In depth knowledge of, and skill in applying, applicable clinical research regulatory requirements; e.g. Good Clinical Practice (GCP) and International Conference on Harmonization (ICH) guidelines.
- Demonstrated ability to understand customer needs, have difficult conversations with internal/external stakeholders and customers, negotiate solutions and understand impacts on the overall offering.
- Strong clinical research skills and commitment to evidence-based and patient-centered clinical development.
#LI-Remote
#LI-NITINMAHAJAN
IQVIA is a leading global provider of clinical research services, commercial insights and healthcare intelligence to the life sciences and healthcare industries. We create intelligent connections to accelerate the development and commercialization of innovative medical treatments to help improve patient outcomes and population health worldwide. Learn more at https://jobs.iqvia.com
IQVIA is proud to be an equal opportunity employer. All qualified applicants will receive consideration for employment without regard to race, color, religion, sex, sexual orientation, gender identity, national origin, disability, status as a protected veteran, or any other status protected by applicable law. https://jobs.iqvia.com/eoe
IQVIA is committed to integrity in our hiring process and maintains a zero tolerance policy for candidate fraud. All information and credentials submitted in your application must be truthful and complete. Any false statements, misrepresentations, or material omissions during the recruitment process will result in immediate disqualification of your application, or termination of employment if discovered later, in accordance with applicable law. We appreciate your honesty and professionalism.
The potential base pay range for this role, when annualized, is $186,300.00 - $519,000.00. The actual base pay offered may vary based on a number of factors including job-related qualifications such as knowledge, skills, education, and experience; location; and/or schedule (full or part-time). Dependent on the position offered, incentive plans, bonuses, and/or other forms of compensation may be offered, in addition to a range of health and welfare and/or other benefits.
About IQVIA
Sourced by ZipRecruiter
At IQVIA, we are passionate about helping customers and partners improve results and patient outcomes. Everything we do contributes to this vision for creating a healthier world. In today’s healthcare environment, it’s not only about how much data, information, and technology you have at your fingertips – it’s what you do with it. IQVIA is focused on making intelligent connections for customers across the entire healthcare ecosystem to help you drive healthcare forward. Whether that means partnering with novel technology companies to boost patient engagement, leveraging AI & machine learning to accelerate results, or using decentralized trials to reach the right patients wherever they are – we are always looking for smarter ways to move you forward.
Industry
Health care and social assistance
Company size
10,000+ Employees
Headquarters location
Durham, NC, US